Clinical Trial Results

A Postmarketing Study of Lecanemab for the Treatment of Participants With Alzheimer's Disease

N/AOBSERVATIONAL Nutley, New Jersey

RECRUITING

Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)

N/AOBSERVATIONAL Boston, Massachusetts +1 more

RECRUITING

Dominantly Inherited Alzheimer Network (DIAN)

N/AOBSERVATIONAL Jacksonville, Florida +4 more

RECRUITING

Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device

N/AOBSERVATIONAL Chicago, Illinois +4 more

RECRUITING

Crownlands Observing Progression With Neurons Study

N/AOBSERVATIONAL Germantown, Maryland

RECRUITING

A Postmarketing Study of LEQEMBI in South Korean Participants With Alzheimer's Disease

N/AOBSERVATIONAL Nutley, New Jersey

RECRUITING

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

N/AOBSERVATIONAL Atlantis, Florida +4 more

RECRUITING

Wake Forest Alzheimer's Disease Clinical Core

N/AOBSERVATIONAL Winston-Salem, North Carolina

RECRUITING

Retinal Imaging in Neurodegenerative Disease

N/AOBSERVATIONAL Durham, North Carolina

RECRUITING

Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies

N/AOBSERVATIONAL Phoenix, Arizona

RECRUITING

Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

N/AOBSERVATIONAL Columbus, Ohio

RECRUITING

Exploring the Utility of [18F]3F4AP for Demyelination Imaging

PHASE1INTERVENTIONAL New Haven, Connecticut

RECRUITING

Adapting RDAD for DS

NAINTERVENTIONAL Kansas City, Kansas

RECRUITING

δ in Dementia Clinical Trials

NAINTERVENTIONAL San Antonio, Texas

RECRUITING

Biofluid Research on Age-Related or Inherited Neurodegeneration

N/AOBSERVATIONAL Philadelphia, Pennsylvania

RECRUITING

UPenn Observational Research Repository on Neurodegenerative Disease

N/AOBSERVATIONAL Philadelphia, Pennsylvania

RECRUITING

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

PHASE3INTERVENTIONAL Chandler, Arizona +4 more

RECRUITING

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

PHASE3INTERVENTIONAL Scottsdale, Arizona +4 more

RECRUITING

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

PHASE3INTERVENTIONAL Chandler, Arizona +4 more

RECRUITING

Epidemiology and Biomarker Study in Alzheimer's Disease

PHASE3INTERVENTIONAL Houston, Texas +3 more

RECRUITING

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

PHASE3INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)

PHASE3INTERVENTIONAL Gilbert, Arizona +4 more

RECRUITING

[18F]PI-2620 Phase 3 Histopathological Study

PHASE3INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

Biomarker Exploration in Aging, Cognition and Neurodegeneration

PHASE3INTERVENTIONAL Irvine, California

RECRUITING

PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620

PHASE3INTERVENTIONAL Philadelphia, Pennsylvania

RECRUITING